S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
An All-In-One Guide for Trading Metals (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
An All-In-One Guide for Trading Metals (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
An All-In-One Guide for Trading Metals (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
An All-In-One Guide for Trading Metals (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
An All-In-One Guide for Trading Metals (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
An All-In-One Guide for Trading Metals (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
An All-In-One Guide for Trading Metals (Ad)pixel
3 Solar-Energy Stocks Setting Up In Bullish Bases
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
An All-In-One Guide for Trading Metals (Ad)pixel
TG Therapeutics Stock 300% Rally Has Legs Yet
Daqo New Energy Charged Up For New Highs

Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

$19.69
+0.34 (+1.76%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$19.61
$19.95
50-Day Range
$15.47
$19.35
52-Week Range
$12.78
$34.96
Volume
870,745 shs
Average Volume
657,894 shs
Market Capitalization
$11.54 billion
P/E Ratio
13.96
Dividend Yield
2.58%
Price Target
$35.96

Fresenius Medical Care AG & Co. KGaA MarketRank™ Forecast

Analyst Rating
Hold
1.78 Rating Score
Upside/​Downside
82.6% Upside
$35.96 Price Target
Short Interest
Healthy
0.25% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-19.58%
From $1.43 to $1.15 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.35 out of 5 stars

Medical Sector

216th out of 1,026 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

3rd out of 9 stocks

FMS stock logo

About Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock

Fresenius Medical Care AG & Co. KgaA provides products and services for individuals with renal diseases. The firm develops and manufactures health care products, which includes dialysis and non-dialysis products. It operates through the following segments: North America Segment, EMEA Segment, Asia-Pacific Segment and Latin America Segment. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Stock News Headlines

Laser breakthrough could send stock soaring 2,476%
Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...
Laser breakthrough could send stock soaring 2,476%
Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%...Boeing soared 4,238%...L3Harris shot up 1,628%...
3 Stocks With Dividends of 3% or More to Buy on the Dip
Fresenius Medical's (FMS) Q3 Earnings and Revenues Top
10 Best European Dividend Stocks to Buy Now
FMS Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS)
See More Headlines
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

FMS Company Calendar

Last Earnings
11/02/2021
Today
2/08/2023
Next Earnings (Estimated)
2/28/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
122,909
Year Founded
1912

Price Target and Rating

Average Stock Price Forecast
$35.96
High Stock Price Forecast
$72.00
Low Stock Price Forecast
$11.70
Forecasted Upside/Downside
+82.6%
Consensus Rating
Hold
Rating Score (0-4)
1.78
Research Coverage
9 Analysts

Profitability

Net Income
$1.15 billion
Pretax Margin
6.95%

Debt

Sales & Book Value

Annual Sales
$20.85 billion
Cash Flow
$5.50 per share
Book Value
$28.22 per share

Miscellaneous

Free Float
N/A
Market Cap
$11.54 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Helen Giza
    Chief Executive & Financial Officer
  • Franklin W. Maddux
    Global Chief Medical Officer
  • Dominik Heger
    Senior VP, Head-IR & Corporate Communications
  • William Valle
    Chief Executive Officer-North America
  • Katarzyna Mazur-Hofsaess
    CEO-Europe, Middle East & Africa













FMS Stock - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care AG & Co. KGaA stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings
or view top-rated stocks.

What is Fresenius Medical Care AG & Co. KGaA's stock price forecast for 2023?

9 equities research analysts have issued twelve-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $72.00. On average, they anticipate the company's stock price to reach $35.96 in the next year. This suggests a possible upside of 82.2% from the stock's current price.
View analysts price targets for FMS
or view top-rated stocks among Wall Street analysts.

How have FMS shares performed in 2023?

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 on January 1st, 2023. Since then, FMS stock has increased by 20.8% and is now trading at $19.74.
View the best growth stocks for 2023 here
.

Are investors shorting Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of December. As of December 30th, there was short interest totaling 1,280,000 shares, an increase of 14.3% from the December 15th total of 1,120,000 shares. Based on an average trading volume of 1,190,000 shares, the short-interest ratio is presently 1.1 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest
.

When is Fresenius Medical Care AG & Co. KGaA's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our FMS earnings forecast
.

How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.55 earnings per share for the quarter, hitting the consensus estimate of $0.55. The company earned $5.24 billion during the quarter, compared to analysts' expectations of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.01% and a trailing twelve-month return on equity of 6.03%.

How often does Fresenius Medical Care AG & Co. KGaA pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Stockholders of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date is Friday, May 13th.
Read our dividend analysis for FMS
.

Is Fresenius Medical Care AG & Co. KGaA a good dividend stock?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.58%. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 42.61% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

What is Fresenius Medical Care AG & Co. KGaA's stock symbol?

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Who are Fresenius Medical Care AG & Co. KGaA's major shareholders?

Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (4.15%), Pacer Advisors Inc. (0.02%), Capricorn Fund Managers Ltd (0.02%), Crossmark Global Holdings Inc. (0.01%), First Heartland Consultants Inc. (0.01%) and Hardman Johnston Global Advisors LLC (0.01%).

How do I buy shares of Fresenius Medical Care AG & Co. KGaA?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius Medical Care AG & Co. KGaA's stock price today?

One share of FMS stock can currently be purchased for approximately $19.74.

How much money does Fresenius Medical Care AG & Co. KGaA make?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $11.57 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does Fresenius Medical Care AG & Co. KGaA have?

The company employs 122,909 workers across the globe.

Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries?
The following companies are subsidiares of Fresenius Medical Care AG & Co. KGaA: NxStage Medical.
Read More
How can I contact Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.

This page (NYSE:FMS) was last updated on 2/9/2023 by MarketBeat.com Staff